Lipopolysaccharides from <i>Porphyromonas gingivalis</i> indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease
BackgroundLipopolysaccharides from <i>Porphyromonas gingivali</i>s (<i>P.g</i>LPS) are involved in the pathology of Alzheimer's disease (AD). However, the effect of <i>P.g</i>LPS on synaptic defects remains unclear.ObjectiveIn this study, we tested our hypothesis that <i>P.g</i>LPS induces synaptic defects in a low-amyloid-beta (Aβ)-concentration environment.MethodsMG6 microglia or N2a neurons was treated with <i>P.g</i>LPS (0.1 μg/mL), soluble Aβ<sub>42</sub> (0.1 μM) or AL (combined <i>P.g</i>LPS and soluble Aβ<sub>42</sub> at 0.1 μM).ResultsIn cultured MG6 microglia, increased the mRNA expression of TNF-α, IL-1β and IL-6 and the TNF-α release in parallel with increased NF-κB activation. In cultured N2a neurons, treatment with Aβ<sub>42</sub>, <i>P.g</i>LPS, and AL did not affect the mRNA expression of synapsin1 (SYN1) or post-synaptic density protein-95 (PSD-95). However, the treatment with conditioned medium from AL-exposed MG6 microglia (AL-MCM) significantly reduced the mRNA and protein expression of SYN1, PSD-95, and nuclear translocation of repressor element-1 silencing transcription factor (REST) but significantly increased the mRNA expression of TNF receptor type I (at 48 h) and glycogen synthase kinase (GSK)3β (at 24 h). TWS119 pretreatment (5 μM), a GSK3β specific inhibitor, significantly reversed the AL-MCM-induced reduction in the mRNA expression of SYN1 and PSD-95 and nuclear translocation of REST in cultured N2a neurons. In APP<sup>NL-F/NL-F</sup> mice, the immunofluorescence intensity of SYN1 and PSD-95 in cortical neurons was positively correlated with the index of the memory test but negatively correlated with that of TNF-α-positive microglia.ConclusionsThese observations demonstrate that <i>P.g</i>LPS induces neuronal GSK3β-dependent synaptic defects in a low-Aβ concentration environment via microglial activation.
Authors
- Tomomi Sano (ORCID: https://orcid.org/0000-0001-8342-0315)
- Junjun Ni (ORCID: https://orcid.org/0000-0001-8486-8146)
- Takashi Kanematsu (ORCID: https://orcid.org/0000-0001-8592-0831)
- Hiroshi Nakanishi (ORCID: https://orcid.org/0000-0003-2610-3203)
- Saori Nonaka (ORCID: https://orcid.org/0000-0003-2672-3082)
- Zhou Wu (ORCID: https://orcid.org/0000-0002-4910-9037)
- Masafumi Moriyama (ORCID: https://orcid.org/0000-0003-2911-2244)
- Shuge Gui (ORCID: https://orcid.org/0009-0004-3966-1102)
- Fan Zeng (ORCID: https://orcid.org/0000-0002-4016-7302)
Institutions
- Beijing Institute of Technology (CN)
- Kyushu University (JP)
- Chinese Academy of Sciences (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- Yasuda Women's University (JP)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1177/13872877251326879
- Citations
- 2
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.33